Previous meta-analyses of cancer patients indicated that several ratios of pretreatment systemic inflammatory markers or/and nutritional markers, such as the neutrophil-lymphocyte ratio (NLR) [14], the albumin-globulin ratio (AGR) [15], and the C-reactive protein-albumin ratio (CAR) [16], can predict prognosis. The gene discussed is ALB; the disease is cancer.